Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Page 1
Update on microbiota-derived therapies for recurrent Clostridioides difficile infections.
Benech N, Barbut F, Fitzpatrick F, Krutova M, Davies K, Druart C, Cordaillat-Simmons M, Heritage J, Guery B, Kuijper E; ESGCD and ESGHAMI. Benech N, et al. Among authors: barbut f. Clin Microbiol Infect. 2024 Apr;30(4):462-468. doi: 10.1016/j.cmi.2023.12.007. Epub 2023 Dec 14. Clin Microbiol Infect. 2024. PMID: 38101472 Review.
IMPLICATIONS: Stool-derived products and bacterial consortia need to be clearly distinguished in terms of product characterization and their associated risks with specific long-term post-marketing evaluation similar to registries used for FMT. ...
IMPLICATIONS: Stool-derived products and bacterial consortia need to be clearly distinguished in terms of product characterization and their …
Molecular epidemiology and antimicrobial resistance patterns of Clostridioides difficile isolates in Algerian hospitals.
Boudjelal Y, Krutova M, Djebbar A, Sebaihia M, Bekara MEA, Rouabhia S, Couturier J, Syed-Zaidi R, Barbut F. Boudjelal Y, et al. Among authors: barbut f. J Infect Dev Ctries. 2022 Jun 30;16(6):1055-1063. doi: 10.3855/jidc.16056. J Infect Dev Ctries. 2022. PMID: 35797301 Free article.
This study highlighted a relatively high genetic diversity in term of ribotypes, sequence types, toxin and antibiotic resistance patterns, in the C. difficile isolates. ...
This study highlighted a relatively high genetic diversity in term of ribotypes, sequence types, toxin and antibiotic resistance patt …
Factors affecting reported Clostridioides difficile infection rates; the more you look the more you find, but should you believe what you see?
Davies K, Davis G, Barbut F, Eckert C, Petrosillo N, Pisapia R, Gärtner B, Berger FK, Reigadas E, Bouza E, Demont C, Wilcox MH. Davies K, et al. Among authors: barbut f. Anaerobe. 2020 Apr;62:102178. doi: 10.1016/j.anaerobe.2020.102178. Epub 2020 Feb 22. Anaerobe. 2020. PMID: 32092415 Free article.
After adjusting for test-density, highest incidence rates were still in Italy, acute/primary hospitals and those using NO-TOXIN. The relative rate in long-term healthcare facilities (LTHCFs) increased, but size of institution no longer influenced the CDI rate. ...
After adjusting for test-density, highest incidence rates were still in Italy, acute/primary hospitals and those using NO-TOXIN. The relativ …
Development and Validation of a Clostridium difficile Health-related Quality-of-Life Questionnaire.
Garey KW, Aitken SL, Gschwind L, Goddu S, Xie Y, Duff C, Barbut F, Shah DN, DuPont HL. Garey KW, et al. Among authors: barbut f. J Clin Gastroenterol. 2016 Sep;50(8):631-7. doi: 10.1097/MCG.0000000000000473. J Clin Gastroenterol. 2016. PMID: 26796081 Free PMC article.
GOALS AND BACKGROUND: Patients with Clostridium difficile infection (CDI) can experience long-term symptoms and poor quality of life due to the disease. Despite this, a health-related quality of life (HRQOL) instrument specific for patients with CDI does not exist. ...
GOALS AND BACKGROUND: Patients with Clostridium difficile infection (CDI) can experience long-term symptoms and poor quality of life …
Clinical and microbiological features of Clostridium difficile infections in France: the ICD-RAISIN 2009 national survey.
Eckert C, Coignard B, Hebert M, Tarnaud C, Tessier C, Lemire A, Burghoffer B, Noel D, Barbut F; ICD-Raisin Working Group. Eckert C, et al. Among authors: barbut f. Med Mal Infect. 2013 Feb;43(2):67-74. doi: 10.1016/j.medmal.2013.01.004. Epub 2013 Mar 14. Med Mal Infect. 2013. PMID: 23498135
RESULTS: One hundred and five HCF with acute care wards and 95 with rehabilitation/long-term care (RLTC) wards participated in the 6-month epidemiological study. ...
RESULTS: One hundred and five HCF with acute care wards and 95 with rehabilitation/long-term care (RLTC) wards participated in the 6- …
Long-term control of vancomycin-resistant Enterococcus faecium at the scale of a large multihospital institution: a seven-year experience.
Fournier S, Brossier F, Fortineau N, Gillaizeau F, Akpabie A, Aubry A, Barbut F, Chedhomme FX, Kassis-Chikhani N, Lucet JC, Robert J, Seytre D, Simon I, Vanjak D, Zahar JR, Brun-Buisson C, Jarlier V. Fournier S, et al. Among authors: barbut f. Euro Surveill. 2012 Jul 26;17(30):20229. Euro Surveill. 2012. PMID: 22856512 Free article.
Investigation of a large outbreak of Clostridium difficile PCR-ribotype 027 infections in northern France, 2006-2007 and associated clusters in 2008-2009.
Birgand G, Blanckaert K, Carbonne A, Coignard B, Barbut F, Eckert C, Grandbastien B, Kadi Z, Astagneau P. Birgand G, et al. Among authors: barbut f. Euro Surveill. 2010 Jun 24;15(25):19597. doi: 10.2807/ese.15.25.19597-en. Euro Surveill. 2010. PMID: 20587362 Free article.
Overall, 38 healthcare facilities notified 529 CDIs over a 22-month period, including 281 laboratory-confirmed CDI 027 and 248 non-confirmed CDI 027 cases (incidence rate per 10,000 elective bed days: 1.63, range: 0.07 to 7.94). The cases occurred mainly in long-term care …
Overall, 38 healthcare facilities notified 529 CDIs over a 22-month period, including 281 laboratory-confirmed CDI 027 and 248 non-confirmed …
Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program.
Jarlier V, Trystram D, Brun-Buisson C, Fournier S, Carbonne A, Marty L, Andremont A, Arlet G, Buu-Hoi A, Carlet J, Decré D, Gottot S, Gutmann L, Joly-Guillou ML, Legrand P, Nicolas-Chanoine MH, Soussy CJ, Wolf M, Lucet JC, Aggoune M, Brücker G, Régnier B; Collégiale de Bactériologie-Virologie-Hygiène des Hôpitaux Universitaires de l'Ile de France. Jarlier V, et al. Arch Intern Med. 2010 Mar 22;170(6):552-9. doi: 10.1001/archinternmed.2010.32. Arch Intern Med. 2010. PMID: 20308642 Free article.
BACKGROUND: The Assistance Publique-Hopitaux de Paris (AP-HP) institution administers 38 teaching hospitals (23 acute care and 15 rehabilitation and long-term care hospitals; total, 23 000 beds) scattered across Paris and surrounding suburbs in France. ...The use of ABHR s …
BACKGROUND: The Assistance Publique-Hopitaux de Paris (AP-HP) institution administers 38 teaching hospitals (23 acute care and 15 rehabilita …
[Totally implantable venous access ports: frequency of complications and analysis of bacterial contamination after ablation].
Barbut F, Soukouna S, Lalande V, Garcia ML, Neyme D, de Gramont A, Petit JC. Barbut F, et al. Pathol Biol (Paris). 2004 Dec;52(10):566-74. doi: 10.1016/j.patbio.2004.07.020. Pathol Biol (Paris). 2004. PMID: 15596304 French.
Totally implantable venous access ports (TIVAP) are valuable medical devices for long-term intravenous treatment such as parenteral nutrition, cancer chemotherapy or antiviral therapy. ...
Totally implantable venous access ports (TIVAP) are valuable medical devices for long-term intravenous treatment such as parenteral n …
11 results